The FDA has expanded the indication for Fiasp (insulin aspart injection; Novo Nordisk) 100 Units/mL to include use in insulin infusion pumps to improve glycemic control in adults with type 1 or type 2 ...

Insulin pumps are the most advanced insulin delivery technology available today for people with type 1 and type 2 diabetes. An insulin pump replaces injections with a syringe or insulin pen, using an ...

The expanded approval was based on data from the phase 3 PRONTO-PUMP-2 trial which evaluated Lyumjev vs Humalog for use in insulin pump therapy in 432 adults with type 1 diabetes. The Food and Drug ...

Please provide your email address to receive an email when new articles are posted on . The FDA expanded the indication for insulin aspart injection 100 U/mL to include use in insulin infusion pumps ...

The thin plastic tubing of infusion sets that connect insulin pumps to the body typically need to be changed every two or three days—but a new version in the U.S. more than doubles that timespan. The ...

Pump vs control sites had greater vessel density, fibrosis, fibrinogen, and inflammation including eosinophils, insulin-like-growth factor-1 (IGF-1), and transforming growth factor (TGF) β-3, as well ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A follow-on therapy to insulin aspart was shown to be ...

DUBLIN--(BUSINESS WIRE)--The "Global Infusion Pumps Market (2023 Edition): Analysis By Product Type (Volumetric, Ambulatory, Insulin, PCA, Syringe Pumps, Others), By Indication, End Use, By Region, By ...

addition, the system has multiple safeguards to protect its integrity and prevent unauthorized action. If you are concerned about unauthorized access for any reason, the pump’s radio frequency feature ...

Modern technology remains a privilege, not a right, as families of people with diabetes struggle to afford rising ...

DUBLIN--(BUSINESS WIRE)--The "Insulin Infusion Pumps Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. The global insulin infusion pump ...

Skin reactions at insulin pump infusion sites are common among people with type 1 diabetes who use the devices and can lead to delivery failure, new research suggests. Insulin pump use is increasingly ...